About us
- >
- About us >
- Information >
- Announcement
2024-01-16
Orphan Drug Designation Granted to ENERGI-F703EB by the Committee for Orphan Medicinal Products(COMP) of the European Medicines Agency (EMA)
Energenesis Biomedical was notified by our consultant on January 16, 2024, that our developmental drug, ENERGI-F703EB, has been granted Orphan Drug Designation (ODD) by the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA).